Evidence map›Paper›PMID 38991014›Full record

ArticlePLOS digital health2024

BRSET: A Brazilian Multilabel Ophthalmological Dataset of Retina Fundus Photos.

Luis Filipe Nakayama, David Restrepo, João Matos, Lucas Zago Ribeiro, Fernando Korn Malerbi, Leo Anthony Celi, Caio Saito Regatieri

Abstract read
In one paragraph

Article in PLOS digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. What are you looking at? Modality contribution in multimodal medical deep learning.International journal of computer assisted radiology and surgery · 2026
    Article
  6. Article
  7. Article
  8. Benchmarking Vision Encoders for Image Classification in Ophthalmology.Computational and structural biotechnology journal · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Luis Filipe NakayamaDepartment of Ophthalmology, São Paulo Federal University, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-6847-6748
David RestrepoLaboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-3789-1957
João MatosLaboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-0312-1647
Lucas Zago RibeiroDepartment of Ophthalmology, São Paulo Federal University, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-9130-1500
Fernando Korn MalerbiDepartment of Ophthalmology, São Paulo Federal University, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-6523-5172
Leo Anthony CeliLaboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-6712-6626
Caio Saito RegatieriDepartment of Ophthalmology, São Paulo Federal University, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0003-1511-8696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Brazilian Multilabel Ophthalmological Dataset (BRSET) addresses the scarcity of publicly available ophthalmological datasets in Latin America. BRSET comprises 16,266 color fundus retinal photos from 8,524 Brazilian patients, aiming to enhance data representativeness, serving as a research and teaching tool. It contains sociodemographic information, enabling investigations into differential model performance across demographic groups.

methodsData from three São Paulo outpatient centers yielded demographic and medical information from electronic records, including nationality, age, sex, clinical history, insulin use, and duration of diabetes diagnosis. A retinal specialist labeled images for anatomical features (optic disc, blood vessels, macula), quality control (focus, illumination, image field, artifacts), and pathologies (e.g., diabetic retinopathy). Diabetic retinopathy was graded using International Clinic Diabetic Retinopathy and Scottish Diabetic Retinopathy Grading. Validation used a ConvNext model trained during 50 epochs using a weighted cross entropy loss to avoid overfitting, with 70% training (20% validation), and 30% testing subsets. Performance metrics included area under the receiver operating curve (AUC) and Macro F1-score. Saliency maps were calculated for interpretability.

resultsBRSET comprises 65.1% Canon CR2 and 34.9% Nikon NF5050 images. 61.8% of the patients are female, and the average age is 57.6 (± 18.26) years. Diabetic retinopathy affected 15.8% of patients, across a spectrum of disease severity. Anatomically, 20.2% showed abnormal optic discs, 4.9% abnormal blood vessels, and 28.8% abnormal macula. A ConvNext V2 model was trained and evaluated BRSET in four prediction tasks: "binary diabetic retinopathy diagnosis (Normal vs Diabetic Retinopathy)" (AUC: 97, F1: 89); "3 class diabetic retinopathy diagnosis (Normal, Proliferative, Non-Proliferative)" (AUC: 97, F1: 82); "diabetes diagnosis" (AUC: 91, F1: 83); "sex classification" (AUC: 87, F1: 70). DISCUSSION: BRSET is the first multilabel ophthalmological dataset in Brazil and Latin America. It provides an opportunity for investigating model biases by evaluating performance across demographic groups. The model performance of three prediction tasks demonstrates the value of the dataset for external validation and for teaching medical computer vision to learners in Latin America using locally relevant data sources.

Identifiers

PMID38991014
PMCPMC11239107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.